622 related articles for article (PubMed ID: 8326180)
41. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
42. Circulating immune complexes in human tuberculosis sera: demonstration of specific antibodies against Mycobacterium tuberculosis glycolipid (DAT, PGLTb1, LOS) antigens in isolated circulating immune complexes.
Simonney N; Molina JM; Molimard M; Oksenhendler E; Lagrange PH
Eur J Clin Invest; 1997 Feb; 27(2):128-34. PubMed ID: 9061306
[TBL] [Abstract][Full Text] [Related]
43. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
44. A serologic study of naturally acquired leprosy in chimpanzees.
Gormus BJ; Xu KY; Alford PL; Lee DR; Hubbard GB; Eichberg JW; Meyers WM
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):450-7. PubMed ID: 1890369
[TBL] [Abstract][Full Text] [Related]
45. Assessment of anti-phenolic glycolipid-I IgM levels using an ELISA for detection of M. leprae infection in populations of the South Pacific Islands.
Cartel JL; Chanteau S; Boutin JP; Plichart R; Richez P; Roux JF; Grosset JH
Int J Lepr Other Mycobact Dis; 1990 Sep; 58(3):512-7. PubMed ID: 2205686
[TBL] [Abstract][Full Text] [Related]
46. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
47. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
48. IgM anti-phenolic glycolipid I and IgG anti-10-kDa heat shock protein antibodies in sera and immune complexes isolated from leprosy patients with or without erythema nodosum leprosum and contacts.
Rojas RE; Demichelis SO; Sarno EN; Segal-Eiras A
FEMS Immunol Med Microbiol; 1997 Sep; 19(1):65-74. PubMed ID: 9322070
[TBL] [Abstract][Full Text] [Related]
49. Analysis of circulating immune complexes from leprosy patients for Mycobacterium leprae antigens.
Sinha S; Chaturvedi V; Mishra B; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):396-403. PubMed ID: 1282143
[TBL] [Abstract][Full Text] [Related]
50. Immunological profiles of leprosy patients and healthy family contacts toward M. leprae antigens.
Ilangumaran S; Ramanathan S; Shankernarayan N; Ramu G; Muthukkarauppan V
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):6-14. PubMed ID: 8627115
[TBL] [Abstract][Full Text] [Related]
51. Identification of components of IC purified from human sera. II. Demonstration of mycobacterial antigens in immune complexes isolated from sera of lepromatous patients.
Chakrabarty AK; Maire M; Saha K; Lambert PH
Clin Exp Immunol; 1983 Feb; 51(2):225-31. PubMed ID: 6340869
[TBL] [Abstract][Full Text] [Related]
52. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
53. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
54. Fractionation, characterization and diagnostic potential of circulating leprosy antigens isolated from sera of lepromatous leprosy patients.
Narayan R; Maheshwari PK; Harinath BC
Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):22-8. PubMed ID: 9614836
[TBL] [Abstract][Full Text] [Related]
55. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
[TBL] [Abstract][Full Text] [Related]
56. Detection of M. leprae-specific antigens with dot-ELISA in urine and nasal samples from leprosy patients.
Singh NB; Choudhary A; Bhatnagar S
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):398-404. PubMed ID: 1890363
[TBL] [Abstract][Full Text] [Related]
57. Enhanced response of serum IgG class of anti-PGL-I antibodies in leprosy patients during onset and following clinical remission of type 1 and type 2 reactions.
Saha K; Chattopadhya D; Kashyup A; Agarwal U; Chakrabarty AK
Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):105-9. PubMed ID: 7730708
[No Abstract] [Full Text] [Related]
58. Analysis of circulating immune complexes (CICs) in childhood tuberculosis: levels of specific antibodies to glycolipid antigens and relationship with serum antibodies.
Simonney N; Bourrillon A; Lagrange PH
Int J Tuberc Lung Dis; 2000 Feb; 4(2):152-60. PubMed ID: 10694094
[TBL] [Abstract][Full Text] [Related]
59. Antibody-based enzyme-linked immunosorbent assay for determination of anti-PGL-I specific circulating immune complex in leprosy patients.
Tomimori-Yamashita J; Cruaud P; Rotta O; Lagrange PH
Lepr Rev; 1999 Sep; 70(3):261-71. PubMed ID: 10603715
[TBL] [Abstract][Full Text] [Related]
60. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
Britton WJ; Garsia RJ; Basten A
Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
